Home/Filings/4/0001127602-24-014855
4//SEC Filing

Grygiel Nancy A. 4

Accession 0001127602-24-014855

CIK 0000318154other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 7:05 PM ET

Size

9.0 KB

Accession

0001127602-24-014855

Insider Transaction Report

Form 4
Period: 2024-05-07
Transactions
  • Award

    Common Stock

    2024-05-07+49910,300 total
  • Award

    Nqso (Right to Buy)

    2024-05-07$300.30/sh+3,244$974,1733,244 total
    Exercise: $300.30From: 2026-05-07Exp: 2034-05-07Common Stock (3,244 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    99.965
Footnotes (5)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
  • [F2]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,780 RSUs which will vest on 7/31/2024; 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027; and 499 RSUs which will vest in installments of 164 on 5/7/2026, 165 on 5/7/2027, and 170 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 424 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
  • [F5]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001816414

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:05 PM ET
Size
9.0 KB